Concepedia

Publication | Closed Access

IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer

DOI

45

Citations

32

References

2018

Year

Hassan Yousefi, Majid Momeny, Seyed H. Ghaffari, Nazanin Parsanejad, Arash Poursheikhani, Sepehr Javadikooshesh, Ghazaleh Zarrinrad, Fatemeh Esmaeili, Zivar Alishahi, Zahra Sabourinejad,
Tumori Journal

Abstract

Collectively, our findings suggest that blockade of the IL-6 signaling pathway with anti-IL-6 receptor antibody tocilizumab might resensitize the chemoresistant cells to the current chemotherapeutics.

References

YearCitations

Page 1